Citations (49)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Fawaz N. S. Al-Heibshy, Ebru Başaran, Rana Arslan, Naile Öztürk, İmran Vural & Müzeyyen Demirel. (2019) Preparation, characterization and pharmacokinetic evaluation of rosuvastatin calcium incorporated cyclodextrin-polyanhydride nanoparticles. Drug Development and Industrial Pharmacy 45:10, pages 1635-1645.
Read now
Read now
Burak Çelik, Samet Özdemir, Aslı Barla Demirkoz & Melike Üner. (2017) Optimization of piribedil mucoadhesive tablets for efficient therapy of Parkinson’s disease: physical characterization and ex vivo drug permeation through buccal mucosa. Drug Development and Industrial Pharmacy 43:11, pages 1836-1845.
Read now
Read now
Anthony A Attama & Chukwuebuka E Umeyor. (2015) The Use of Solid Lipid Nanoparticles for Sustained Drug Release. Therapeutic Delivery 6:6, pages 669-684.
Read now
Read now
Santo Scalia, Paul M Young & Daniela Traini. (2015) Solid lipid microparticles as an approach to drug delivery. Expert Opinion on Drug Delivery 12:4, pages 583-599.
Read now
Read now
Lütfi Genç. (2014) Preparation and characterization of nocodazole-loaded solid lipid nanoparticles. Pharmaceutical Development and Technology 19:6, pages 671-676.
Read now
Read now
Jaleh Varshosaz, Majid Tabbakhian & Mahboobeh Y. Mohammadi. (2010) Formulation and optimization of solid lipid nanoparticles of buspirone HCl for enhancement of its oral bioavailability. Journal of Liposome Research 20:4, pages 286-296.
Read now
Read now
Evren H Gokce, Mine Ozyazici & Eliana B Souto. (2010) Nanoparticulate Strategies for Effective Delivery of Poorly Soluble Therapeutics. Therapeutic Delivery 1:1, pages 149-167.
Read now
Read now
Melike Üner & Gülgün Yener. (2007) Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives. International Journal of Nanomedicine 2:3, pages 289-300.
Read now
Read now
Alfred Fahr & Xiangli Liu. (2007) Drug delivery strategies for poorly water-soluble drugs. Expert Opinion on Drug Delivery 4:4, pages 403-416.
Read now
Read now
Kopparam Manjunath & Vobalaboina Venkateswarlu. (2006) Pharmacokinetics, tissue distribution and bioavailability of nitrendipine solid lipid nanoparticles after intravenous and intraduodenal administration. Journal of Drug Targeting 14:9, pages 632-645.
Read now
Read now
Articles from other publishers (39)
CHEKKILLA BHARGAVI & PATHURI RAGHUVEER. (2024) ENHANCING NOSE- TO- BRAIN DELIVERY OF PIRIBEDIL: DEVELOPMENT OF A NANOSUSPENSION DISPERSED IN NASAL IN-SITU GELLING SYSTEM. International Journal of Applied Pharmaceutics, pages 86-101.
Crossref
Crossref
Sarvesh S. Pawar, Punam S. Gadekar, Bhushan R. Rane & Ashish S. Jain. (2024) Formulation of Lipid Nanoparticles based Nanogel of Sertaconazole
Nitrate and its Evaluation. Current Nanomedicine 14:1, pages 28-40.
Crossref
Crossref
João Vitor Raupp de Oliveira, Pedro Leardin Silveira, Gabriela Spingolon, Gabriel Antonio Lopes Alves, Flávia Pires Peña & Tanira Alessandra Silveira Aguirre. (2023) Polymeric nanoparticles containing babassu oil: A proposed drug delivery system for controlled release of hydrophilic compounds. Chemistry and Physics of Lipids 253, pages 105304.
Crossref
Crossref
Bwalya Angel Witika, Madan Sai Poka, Patrick Hulisani Demana, Scott Kaba Matafwali, Siyabonga Melamane, Sandile Maswazi Malungelo Khamanga & Pedzisai Anotida Makoni. (2022) Lipid-Based Nanocarriers for Neurological Disorders: A Review of the State-of-the-Art and Therapeutic Success to Date. Pharmaceutics 14:4, pages 836.
Crossref
Crossref
Sartini Sartini, Andi Dian Permana, Saikat Mitra, Abu Montakim Tareq, Emil Salim, Islamudin Ahmad, Harapan Harapan, Talha Bin Emran & Firzan Nainu. (2021) Current State and Promising Opportunities on Pharmaceutical Approaches in the Treatment of Polymicrobial Diseases. Pathogens 10:2, pages 245.
Crossref
Crossref
Sara Yazdi, David J. Chen & David Putnam. (2021) Microparticle fabricated from a series of symmetrical lipids based on dihydroxyacetone form textured architectures. Journal of Controlled Release 330, pages 1071-1079.
Crossref
Crossref
Rimpy Diwan, Punna Rao Ravi, Nikita Shantaram Pathare & Vidushi Aggarwal. (2020) Pharmacodynamic, pharmacokinetic and physical characterization of cilnidipine loaded solid lipid nanoparticles for oral delivery optimized using the principles of design of experiments. Colloids and Surfaces B: Biointerfaces 193, pages 111073.
Crossref
Crossref
Fawaz N.S. Al-Heibshy, Ebru Başaran, Rana Arslan, Naile Öztürk, Kevser Erol & Müzeyyen Demirel. (2020) Physicochemical characterization and pharmacokinetic evaluation of rosuvastatin calcium incorporated solid lipid nanoparticles. International Journal of Pharmaceutics 578, pages 119106.
Crossref
Crossref
Govindarajan Karthivashan, Palanivel Ganesan, Shin-Young Park, Ho-Won Lee & Dong-Kug Choi. (2020) Lipid-based nanodelivery approaches for dopamine-replacement therapies in Parkinson's disease: From preclinical to translational studies. Biomaterials 232, pages 119704.
Crossref
Crossref
Md. Mehedi Hasan, Adib H. Chisty, Mohammed Mizanur Rahman & M. Nuruzzaman Khan. 2020. Interpenetrating Polymer Network: Biomedical Applications. Interpenetrating Polymer Network: Biomedical Applications
183
203
.
Abhishek Pandey. 2020. Nanoscience in Medicine Vol. 1. Nanoscience in Medicine Vol. 1
249
295
.
Ritika Kondel, Nusrat Shafiq, Indu P. Kaur, Mini P. Singh, Avaneesh K. Pandey, Radha K. Ratho & Samir Malhotra. (2019) Effect of Acyclovir Solid Lipid Nanoparticles for the Treatment of Herpes Simplex Virus (HSV) Infection in an Animal Model of HSV-1 Infection. Pharmaceutical Nanotechnology 7:5, pages 389-403.
Crossref
Crossref
Josef Jampílek, Katarína Kráľová, Petr Novák & Michal Novák. 2019. Nanobiotechnology in Neurodegenerative Diseases. Nanobiotechnology in Neurodegenerative Diseases
65
138
.
Ilyes Dammak & Paulo José do Amaral Sobral. (2018) Effect of different biopolymers on the stability of hesperidin-encapsulating O/W emulsions. Journal of Food Engineering 237, pages 33-43.
Crossref
Crossref
Chandra Teja Uppuluri, Avantika V. Dalvi, Ekta Prasanthi Bommireddy & Punna Rao Ravi. (2018) Development and validation of rapid and sensitive LC methods with PDA and fluorescence detection for determination of piribedil in rat plasma and brain tissues and their pharmacokinetic application. Biomedical Chromatography 32:10.
Crossref
Crossref
Yung-Chih Kuo & Rajendiran Rajesh. (2018) Current development of nanocarrier delivery systems for Parkinson's disease pharmacotherapy. Journal of the Taiwan Institute of Chemical Engineers 87, pages 15-25.
Crossref
Crossref
. 2017. Nanomedicine in Cancer. Nanomedicine in Cancer
99
128
.
Ameya Deshpande, Majrad Mohamed, Saloni B. Daftardar, Meghavi Patel, Sai H.S. Boddu & Jerry Nesamony. 2017. Emerging Nanotechnologies for Diagnostics, Drug Delivery and Medical Devices. Emerging Nanotechnologies for Diagnostics, Drug Delivery and Medical Devices
291
330
.
Rajashekar Kammari, Nandita G. Das & Sudip K. Das. 2017. Emerging Nanotechnologies for Diagnostics, Drug Delivery and Medical Devices. Emerging Nanotechnologies for Diagnostics, Drug Delivery and Medical Devices
105
144
.
Gabriel Henrique Hawthorne, Marcelo Picinin Bernuci, Mariza Bortolanza, Vitor Tumas, Ana Carolina Issy & Elaine Del-Bel. (2016) Nanomedicine to Overcome Current Parkinson’s Treatment Liabilities: A Systematic Review. Neurotoxicity Research 30:4, pages 715-729.
Crossref
Crossref
Santiago Perez-Lloret & Olivier Rascol. (2016) Piribedil for the Treatment of Motor and Non-motor Symptoms of Parkinson Disease. CNS Drugs 30:8, pages 703-717.
Crossref
Crossref
Hossein Ali Ebrahimi, Yousef Javadzadeh, Mehrdad Hamidi & Mohammad Barzegar Jalali. (2015) Repaglinide-loaded solid lipid nanoparticles: effect of using different surfactants/stabilizers on physicochemical properties of nanoparticles. DARU Journal of Pharmaceutical Sciences 23:1.
Crossref
Crossref
Sara Laserra, Abdul Basit, Piera Sozio, Lisa Marinelli, Erika Fornasari, Ivana Cacciatore, Michele Ciulla, Hasan Türkez, Fatime Geyikoglu & Antonio Di Stefano. (2015) Solid lipid nanoparticles loaded with lipoyl–memantine codrug: Preparation and characterization. International Journal of Pharmaceutics 485:1-2, pages 183-191.
Crossref
Crossref
Engy R. Rashed, Hassan A. Abd El‐Rehim & Mona A. El‐Ghazaly. (2014) Potential efficacy of dopamine loaded‐PVP/PAA nanogel in experimental models of Parkinsonism: Possible disease modifying activity. Journal of Biomedical Materials Research Part A 103:5, pages 1713-1720.
Crossref
Crossref
Mustafa Cengiz, H. Mehtap Kutlu, Dilek D. Burukoglu & Adnan Ayhancı. (2015) A comparative study on the therapeutic effects of Silymarin and Silymarin-Loaded Solid Lipid Nanoparticles on D-GaIN/TNF-α-induced Liver Damage in Balb/c Mice. Food and Chemical Toxicology 77, pages 93-100.
Crossref
Crossref
Adriana Trapani, Delia Mandracchia, Cinzia Di Franco, Héctor Cordero, Patricia Morcillo, Roberto Comparelli, Alberto Cuesta & Maria Angeles Esteban. (2015) In vitro characterization of 6-Coumarin loaded solid lipid nanoparticles and their uptake by immunocompetent fish cells. Colloids and Surfaces B: Biointerfaces 127, pages 79-88.
Crossref
Crossref
Kovoru Krishnam Raju, Beeravelli Sudhakar & Kolapalli Venkata Ramana Murthy. (2014) Factorial Design Studies and Biopharmaceutical Evaluation of Simvastatin Loaded Solid Lipid Nanoparticles for Improving the Oral Bioavailability. ISRN Nanotechnology 2014, pages 1-8.
Crossref
Crossref
M.Gulrez Zariwala, Naba Elsaid, Timothy L. Jackson, Francisco Corral López, Sebastien Farnaud, Satyanarayana Somavarapu & Derek Renshaw. (2013) A novel approach to oral iron delivery using ferrous sulphate loaded solid lipid nanoparticles. International Journal of Pharmaceutics 456:2, pages 400-407.
Crossref
Crossref
Sacheen Kumar & Jaspreet Kaur Randhawa. (2013) High melting lipid based approach for drug delivery: Solid lipid nanoparticles. Materials Science and Engineering: C 33:4, pages 1842-1852.
Crossref
Crossref
Adriana Trapani, Elvira De Giglio, Damiana Cafagna, Nunzio Denora, Gennaro Agrimi, Tommaso Cassano, Silvana Gaetani, Vincenzo Cuomo & Giuseppe Trapani. (2011) Characterization and evaluation of chitosan nanoparticles for dopamine brain delivery. International Journal of Pharmaceutics 419:1-2, pages 296-307.
Crossref
Crossref
Yao-Da Dong & Ben J. Boyd. (2011) Applications of X-ray scattering in pharmaceutical science. International Journal of Pharmaceutics 417:1-2, pages 101-111.
Crossref
Crossref
Donald J. AbrahamIjeoma F. Uchegbu & Andreas G. Schatzlein. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
469
492
.
Indu Pal Kaur, Rohit Bhandari, Swati Bhandari & Vandita Kakkar. (2008) Potential of solid lipid nanoparticles in brain targeting. Journal of Controlled Release 127:2, pages 97-109.
Crossref
Crossref
Maria Rosa Gasco. 2007. Nanoparticulate Drug Delivery Systems. Nanoparticulate Drug Delivery Systems
305
316
.
Kopparam Manjunath & Vobalaboina Venkateswarlu. (2005) Pharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administration. Journal of Controlled Release 107:2, pages 215-228.
Crossref
Crossref
I. El-Gibaly & S.K. Abdel-Ghaffar. (2005) Effect of hexacosanol on the characteristics of novel sustained-release allopurinol solid lipospheres (SLS): factorial design application and product evaluation. International Journal of Pharmaceutics 294:1-2, pages 33-51.
Crossref
Crossref
Heike Bunjes. 2004. Lipospheres in Drug Targets and Delivery. Lipospheres in Drug Targets and Delivery
41
66
.
S.A Wissing, O Kayser & R.H Müller. (2004) Solid lipid nanoparticles for parenteral drug delivery. Advanced Drug Delivery Reviews 56:9, pages 1257-1272.
Crossref
Crossref
José Luis Pedraz, Gorka Orive, Manoli Igartua, Alicia R. Gascón, Rosa M. Hernández, Maria Angeles Solinis & Amaia Esquisabel. 2007. Nanotechnologies for the Life Sciences. Nanotechnologies for the Life Sciences.